Delivery Order SPE2DB22D2006-SPE2DB24FV7ZT
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,385.61, is for the delivery of 4,567,141,954 units of Hydroxyzine 50 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through March 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of hydroxyzine hydrochloride 50 mg tablets, a prescription medication. The contract has a ceiling value of $1,009.69 and runs through October 18, 2023. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,952 units of Hydroxyzine HCl 10 mg tablets, a pharmaceutical product. The contract has a ceiling value of $25,357.31 and is a firm fixed-price delivery order contract with a performance period ending on December 1, 2023. The contract was awarded on November 30, 2023 and is not designated as a set-aside....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,564,426,800 units of Hydroxyzine HCL 10 mg tablets, a prescription medication, at a ceiling value of $4,083.06. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This award is not set aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for 4,565,425,023 units of the pharmaceutical product Hydroxyzine 50 mg/ml, with a ceiling value of $5,006.59. The contract type is Firm Fixed Price and the completion date is August 13, 2024. This order is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,412.55 firm fixed-price contract is for the supply of hydroxyzine 100 mg/2 ml vials. The contract has an ultimate completion date of May 8, 2023 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,777.13, is for the delivery of hydroxyzine 50 mg/mL vials. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA for providing a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award, valued at $7,169.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of hydroxyzine 50 mg/ml vials, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,611.20, is for the delivery of hydroxyzine 50mg tablets. The contract has an ultimate completion date of January 8, 2025 and was awarded on December 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 50 mg/mL hydroxyzine vials. The contract has a ceiling value of $1,801.04 and a completion date of May 28, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV7ZTDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $40,875.03 and runs through February 7, 2024. It is a firm-fixed-price contract for the supply of 4,563,574,108 units of hydroxyzine hydrochloride 10 mg tablets. The contract was not designated as a set-aside and was openly competed. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.9k | 2/6/24 |